Optimal Use of New Fentanyl Formulations for BTCP in Asia

Slides:



Advertisements
Similar presentations
Guidelines for Pain Management Paula Wilkinson Chief Pharmacist NHS Mid-Essex.
Advertisements

Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 05: Relieving Pain and Providing Comfort.
August 16, 2015 Equianalgesia Opioid Calculator: JHH Applications Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management Department.
BeCOn OWN Educational Program
PATIENT CASE Module 4 Date of preparation: June 2015 HQ/EFF/15/0024h.
Katy Trinkley, PharmDAngie Thompson, PharmD.  Opioid risks and risk prevention strategies  Medication treatment by pain type  Fundamental principles.
Pain II: Cancer Pain Management Dr. Leah Steinberg.
Dominique A. Lossignola and Cristina Dumitrescu Current Opinion in Oncology 2010, 22:302–306 R2 박소영 /prof. 이재진.
What's New in Basal Insulin for Diabetes
Introduction. Adult ADHD in the Real World: From Clinical Trials to Clinical Practice.
Dry Eye Disease: Pathophysiology, Symptoms, Intervention
Multimodal Management of Opioid-Induced Constipation
This program will include a discussion of off-label treatment not approved by the FDA for use in the United States.
Challenges and Opportunities in the Management of ANCA-Associated Vasculitis.
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL
Making Decisions With Your Osteoarthritis Patients
A Fresh Look at Dry Eye.
Maximizing Medical Management of Knee Osteoarthritis
Optimizing Therapy for Osteoarthritis
This program will include a discussion of off-label treatment and devices and investigational agents and devices not approved by the FDA for use in the.
New Patient Journeys in Non-small cell lung cancer
The Nurse View.
Modern Strategies for Basal Insulin Use in T2D
Emergency Analgesia in the Trauma Setting in Adults
Clinical Review.
Biological Therapy in Psoriasis: Recognizing the Value
Patient-Centered Care in Cystic Fibrosis
The Cancer Pain Journey: Optimizing Identification and Management
Beyond the Basics: What You Need to Know About Treating Insomnia
Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Lessons Learned In Opioid Treatment From the Pain Action Consulting Team.
Heart Failure Prevention: Mission Impossible?
GLP-1 Receptor Agonists: How Early Is Appropriate?
Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief  Giovambattista Zeppetella, FRCP  Journal.
Treating HFrEF: Challenges Faced
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.
Case Collection in RA: Highlights of an Interactive Workshop
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Managing Depression is a Team Effort:
Avoiding Opioid Overuse: Guideline-Based Management of Osteoarthritis
Expert Debate in MDD.
A Primer on Medication Delivery Systems in COPD Management
Perspectives on the Impact of Inflammation in OA
The Importance of Getting the Dose Right in HF
An Interprofessional Perspective on the Safe and Appropriate Use of Opioid Analgesics.
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
A Primer on Medication Delivery Systems in COPD Management
When Is Intrathecal Drug Delivery Appropriate?
Critical Decision Points in Insomnia
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
Iron Deficiency in Heart Failure
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD 
Clinical Challenges and Updates in Managing Seizure Clusters
When Is Intrathecal Drug Delivery Appropriate?
Issues in Patients With Severe Epilepsy
AMD Therapy: Where Are We Now and Where Are We Going?
Rational Pharmacotherapy Selection for Insomnia
PCSK9 Inhibitors and Statin Intolerance
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Uptitration of Medications in HF: Start Low but Aim High and Stay High
SAFE USE OF FENTANYL OROMUCOSAL FORMULATIONS FOR BREAKTHROUGH CANCER PAIN HIGH RISK MEDICINES EDUCATION.
Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.
Examining the Role of Pharmacokinetics in Hemophilia
Risk Factors for Migraine Chronification
Navigating the Journey
Baseline characteristics of people who inject drugs enrolled in the Montreal Hepatitis C Cohort (2004–2017), by prescribed dosage of opioid agonist treatment,
Hazard ratios for associations between incident hepatitis C virus infection and prescribed dosage of opioid agonist treatment, categorized according to.
Presentation transcript:

Optimal Use of New Fentanyl Formulations for BTCP in Asia

Issues in the Optimal Management of BTCP in Asia

ROOs

Patients in Pain Crisis

Which Medication Is Suitable?

Appropriate Patient Selection for Transmucosal Immediate-Relief Fentanyl

End-of-Dose Failure

The Titration Schedule of Sublingual Fentanyl

ROOs

Program Goal

BTCP: Definition

BTCP: Subtypes

Effect of BTCP on QoL

Challenges in the Treatment of BTCP

APM Guidelines

Current EAPC Recommendations

Comparison of Different Routes of Administration of Fentanyl for BTCP

Considerations When Choosing a Specific Opioid Preparation for BTCP

Dose Titration of Opioid Rescue Medication: APM Recommendations

Clinical Considerations When Treating Patients With BTCP

Abbreviations

Abbreviations (cont)

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.